1.37
|
1.93e-47
|
GO:0044238
|
primary metabolic process
|
1.33
|
4.25e-47
|
GO:0008152
|
metabolic process
|
1.37
|
4.28e-46
|
GO:0044237
|
cellular metabolic process
|
1.56
|
2.39e-40
|
GO:0009058
|
biosynthetic process
|
1.55
|
4.34e-38
|
GO:0044249
|
cellular biosynthetic process
|
1.39
|
1.04e-33
|
GO:0044260
|
cellular macromolecule metabolic process
|
1.36
|
3.60e-33
|
GO:0043170
|
macromolecule metabolic process
|
1.47
|
1.16e-32
|
GO:0034641
|
cellular nitrogen compound metabolic process
|
1.57
|
1.22e-32
|
GO:0010467
|
gene expression
|
1.45
|
1.29e-31
|
GO:0006807
|
nitrogen compound metabolic process
|
1.48
|
2.09e-30
|
GO:0006139
|
nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.56
|
4.83e-29
|
GO:0034645
|
cellular macromolecule biosynthetic process
|
1.55
|
8.23e-29
|
GO:0009059
|
macromolecule biosynthetic process
|
1.51
|
2.98e-27
|
GO:0090304
|
nucleic acid metabolic process
|
1.55
|
3.25e-27
|
GO:0016070
|
RNA metabolic process
|
1.49
|
6.21e-26
|
GO:0031326
|
regulation of cellular biosynthetic process
|
1.48
|
8.16e-26
|
GO:0009889
|
regulation of biosynthetic process
|
1.49
|
1.01e-25
|
GO:0010468
|
regulation of gene expression
|
1.41
|
2.32e-25
|
GO:0031323
|
regulation of cellular metabolic process
|
1.51
|
2.62e-25
|
GO:2000112
|
regulation of cellular macromolecule biosynthetic process
|
1.37
|
1.97e-24
|
GO:0019222
|
regulation of metabolic process
|
1.49
|
2.55e-24
|
GO:0010556
|
regulation of macromolecule biosynthetic process
|
1.40
|
4.12e-24
|
GO:0080090
|
regulation of primary metabolic process
|
1.50
|
1.96e-22
|
GO:0051252
|
regulation of RNA metabolic process
|
1.40
|
2.14e-22
|
GO:0060255
|
regulation of macromolecule metabolic process
|
1.50
|
7.52e-22
|
GO:0006355
|
regulation of transcription, DNA-dependent
|
1.44
|
4.27e-21
|
GO:0019219
|
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.44
|
4.80e-21
|
GO:0051171
|
regulation of nitrogen compound metabolic process
|
1.57
|
1.27e-20
|
GO:0032774
|
RNA biosynthetic process
|
1.57
|
1.62e-20
|
GO:0006351
|
transcription, DNA-dependent
|
1.71
|
1.75e-16
|
GO:0006357
|
regulation of transcription from RNA polymerase II promoter
|
1.34
|
5.33e-15
|
GO:0032502
|
developmental process
|
1.36
|
1.59e-13
|
GO:0048518
|
positive regulation of biological process
|
1.38
|
1.86e-13
|
GO:0048522
|
positive regulation of cellular process
|
1.34
|
2.70e-13
|
GO:0007275
|
multicellular organismal development
|
1.65
|
3.17e-13
|
GO:0031328
|
positive regulation of cellular biosynthetic process
|
1.85
|
8.62e-13
|
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter
|
1.45
|
1.09e-12
|
GO:0048513
|
organ development
|
1.35
|
1.16e-12
|
GO:0048856
|
anatomical structure development
|
1.69
|
1.55e-12
|
GO:0009790
|
embryo development
|
1.62
|
2.06e-12
|
GO:0009891
|
positive regulation of biosynthetic process
|
1.71
|
3.19e-12
|
GO:0045893
|
positive regulation of transcription, DNA-dependent
|
1.39
|
3.81e-12
|
GO:0048523
|
negative regulation of cellular process
|
1.65
|
3.82e-12
|
GO:0010557
|
positive regulation of macromolecule biosynthetic process
|
1.69
|
8.55e-12
|
GO:0051254
|
positive regulation of RNA metabolic process
|
1.11
|
8.76e-12
|
GO:0009987
|
cellular process
|
1.65
|
1.03e-11
|
GO:0045935
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.63
|
1.37e-11
|
GO:0051173
|
positive regulation of nitrogen compound metabolic process
|
1.65
|
2.49e-11
|
GO:0010628
|
positive regulation of gene expression
|
1.50
|
4.13e-11
|
GO:0031325
|
positive regulation of cellular metabolic process
|
1.36
|
6.54e-11
|
GO:0048519
|
negative regulation of biological process
|
1.67
|
9.94e-11
|
GO:0009890
|
negative regulation of biosynthetic process
|
1.35
|
1.14e-10
|
GO:0048731
|
system development
|
1.67
|
1.28e-10
|
GO:0031327
|
negative regulation of cellular biosynthetic process
|
1.68
|
2.71e-10
|
GO:0010558
|
negative regulation of macromolecule biosynthetic process
|
1.57
|
3.45e-10
|
GO:0010605
|
negative regulation of macromolecule metabolic process
|
1.54
|
5.44e-10
|
GO:0009892
|
negative regulation of metabolic process
|
1.81
|
6.00e-10
|
GO:0009792
|
embryo development ending in birth or egg hatching
|
1.68
|
6.33e-10
|
GO:2000113
|
negative regulation of cellular macromolecule biosynthetic process
|
1.46
|
6.48e-10
|
GO:0009893
|
positive regulation of metabolic process
|
1.94
|
6.62e-10
|
GO:0007389
|
pattern specification process
|
1.81
|
8.47e-10
|
GO:0043009
|
chordate embryonic development
|
1.48
|
1.35e-09
|
GO:0010604
|
positive regulation of macromolecule metabolic process
|
1.45
|
4.39e-09
|
GO:0009653
|
anatomical structure morphogenesis
|
2.06
|
4.76e-09
|
GO:0001501
|
skeletal system development
|
1.36
|
5.29e-09
|
GO:0048869
|
cellular developmental process
|
1.41
|
6.37e-09
|
GO:0044281
|
small molecule metabolic process
|
1.65
|
6.72e-09
|
GO:0010629
|
negative regulation of gene expression
|
1.53
|
7.49e-09
|
GO:0031324
|
negative regulation of cellular metabolic process
|
1.36
|
9.61e-09
|
GO:0030154
|
cell differentiation
|
1.28
|
1.10e-08
|
GO:0071840
|
cellular component organization or biogenesis
|
1.55
|
2.73e-08
|
GO:0009888
|
tissue development
|
2.39
|
2.90e-08
|
GO:0048705
|
skeletal system morphogenesis
|
2.05
|
2.94e-08
|
GO:0003002
|
regionalization
|
1.66
|
3.16e-08
|
GO:0051253
|
negative regulation of RNA metabolic process
|
1.81
|
3.76e-08
|
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter
|
1.66
|
4.23e-08
|
GO:0009887
|
organ morphogenesis
|
1.65
|
1.30e-07
|
GO:0045892
|
negative regulation of transcription, DNA-dependent
|
1.58
|
5.95e-07
|
GO:0051172
|
negative regulation of nitrogen compound metabolic process
|
1.50
|
6.21e-07
|
GO:0042127
|
regulation of cell proliferation
|
2.16
|
8.57e-07
|
GO:0009952
|
anterior/posterior pattern formation
|
1.98
|
8.75e-07
|
GO:0061061
|
muscle structure development
|
1.58
|
1.05e-06
|
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.84
|
1.11e-06
|
GO:0010551
|
regulation of gene-specific transcription from RNA polymerase II promoter
|
2.15
|
1.45e-06
|
GO:0022613
|
ribonucleoprotein complex biogenesis
|
2.10
|
2.37e-06
|
GO:0071843
|
cellular component biogenesis at cellular level
|
1.72
|
3.03e-06
|
GO:0048598
|
embryonic morphogenesis
|
1.29
|
3.91e-06
|
GO:0071841
|
cellular component organization or biogenesis at cellular level
|
1.25
|
3.99e-06
|
GO:0016043
|
cellular component organization
|
1.46
|
4.08e-06
|
GO:0044085
|
cellular component biogenesis
|
1.44
|
5.83e-06
|
GO:0050793
|
regulation of developmental process
|
1.87
|
6.65e-06
|
GO:0048568
|
embryonic organ development
|
1.72
|
7.97e-06
|
GO:0032583
|
regulation of gene-specific transcription
|
1.28
|
1.19e-05
|
GO:0044267
|
cellular protein metabolic process
|
1.25
|
1.52e-05
|
GO:0019538
|
protein metabolic process
|
1.70
|
1.58e-05
|
GO:0009719
|
response to endogenous stimulus
|
1.85
|
2.00e-05
|
GO:0006412
|
translation
|
2.28
|
3.16e-05
|
GO:0042254
|
ribosome biogenesis
|
1.42
|
3.41e-05
|
GO:0010941
|
regulation of cell death
|
2.13
|
3.46e-05
|
GO:0048545
|
response to steroid hormone stimulus
|
2.71
|
4.94e-05
|
GO:0048704
|
embryonic skeletal system morphogenesis
|
1.42
|
5.38e-05
|
GO:0042981
|
regulation of apoptosis
|
1.42
|
5.78e-05
|
GO:0043067
|
regulation of programmed cell death
|
1.99
|
9.59e-05
|
GO:0048562
|
embryonic organ morphogenesis
|
2.47
|
1.37e-04
|
GO:0045787
|
positive regulation of cell cycle
|
1.67
|
3.18e-04
|
GO:0009725
|
response to hormone stimulus
|
1.45
|
3.75e-04
|
GO:0045595
|
regulation of cell differentiation
|
1.55
|
4.23e-04
|
GO:0048646
|
anatomical structure formation involved in morphogenesis
|
2.01
|
5.23e-04
|
GO:0007517
|
muscle organ development
|
1.28
|
6.28e-04
|
GO:0065008
|
regulation of biological quality
|
1.71
|
6.30e-04
|
GO:0045596
|
negative regulation of cell differentiation
|
2.00
|
6.56e-04
|
GO:0010553
|
negative regulation of gene-specific transcription from RNA polymerase II promoter
|
2.34
|
7.09e-04
|
GO:0048706
|
embryonic skeletal system development
|
1.42
|
7.38e-04
|
GO:0048468
|
cell development
|
1.24
|
2.53e-03
|
GO:0071842
|
cellular component organization at cellular level
|
2.85
|
2.60e-03
|
GO:0043401
|
steroid hormone mediated signaling pathway
|
1.75
|
2.88e-03
|
GO:0010608
|
posttranscriptional regulation of gene expression
|
1.89
|
3.19e-03
|
GO:0010552
|
positive regulation of gene-specific transcription from RNA polymerase II promoter
|
1.84
|
3.53e-03
|
GO:0032582
|
negative regulation of gene-specific transcription
|
1.78
|
3.75e-03
|
GO:0043193
|
positive regulation of gene-specific transcription
|
1.81
|
4.02e-03
|
GO:0071495
|
cellular response to endogenous stimulus
|
2.01
|
4.50e-03
|
GO:0006417
|
regulation of translation
|
1.38
|
5.03e-03
|
GO:2000026
|
regulation of multicellular organismal development
|
2.27
|
5.14e-03
|
GO:0015931
|
nucleobase, nucleoside, nucleotide and nucleic acid transport
|
1.50
|
5.67e-03
|
GO:0008284
|
positive regulation of cell proliferation
|
1.59
|
5.98e-03
|
GO:0048729
|
tissue morphogenesis
|
2.36
|
6.05e-03
|
GO:0006403
|
RNA localization
|
1.63
|
6.66e-03
|
GO:0035295
|
tube development
|
1.53
|
6.98e-03
|
GO:0044283
|
small molecule biosynthetic process
|
2.22
|
7.02e-03
|
GO:0030879
|
mammary gland development
|
2.37
|
7.78e-03
|
GO:0050657
|
nucleic acid transport
|
2.37
|
7.78e-03
|
GO:0050658
|
RNA transport
|
2.37
|
7.78e-03
|
GO:0051236
|
establishment of RNA localization
|
1.69
|
7.83e-03
|
GO:0040007
|
growth
|
1.85
|
9.03e-03
|
GO:0034470
|
ncRNA processing
|
2.90
|
1.06e-02
|
GO:0017148
|
negative regulation of translation
|
1.43
|
1.19e-02
|
GO:0033554
|
cellular response to stress
|
2.41
|
1.64e-02
|
GO:0071383
|
cellular response to steroid hormone stimulus
|
1.71
|
2.34e-02
|
GO:0034660
|
ncRNA metabolic process
|
1.73
|
2.40e-02
|
GO:0048732
|
gland development
|
1.49
|
2.43e-02
|
GO:0071310
|
cellular response to organic substance
|
1.30
|
2.66e-02
|
GO:0033036
|
macromolecule localization
|
1.61
|
2.66e-02
|
GO:0001701
|
in utero embryonic development
|
2.16
|
2.71e-02
|
GO:0006662
|
glycerol ether metabolic process
|
1.46
|
2.72e-02
|
GO:0072358
|
cardiovascular system development
|
1.46
|
2.72e-02
|
GO:0072359
|
circulatory system development
|
1.58
|
3.08e-02
|
GO:0044271
|
cellular nitrogen compound biosynthetic process
|
2.66
|
3.21e-02
|
GO:0034329
|
cell junction assembly
|
1.54
|
3.30e-02
|
GO:0051093
|
negative regulation of developmental process
|
1.42
|
3.56e-02
|
GO:0006915
|
apoptosis
|
1.49
|
3.69e-02
|
GO:0043066
|
negative regulation of apoptosis
|
1.41
|
3.82e-02
|
GO:0012501
|
programmed cell death
|
1.35
|
3.89e-02
|
GO:0022607
|
cellular component assembly
|
2.36
|
4.04e-02
|
GO:0009755
|
hormone-mediated signaling pathway
|
2.36
|
4.04e-02
|
GO:0048771
|
tissue remodeling
|
1.48
|
4.11e-02
|
GO:0043069
|
negative regulation of programmed cell death
|
1.43
|
4.27e-02
|
GO:0071844
|
cellular component assembly at cellular level
|
2.11
|
4.55e-02
|
GO:0018904
|
organic ether metabolic process
|
1.23
|
4.68e-02
|
GO:0043412
|
macromolecule modification
|
4.56
|
4.99e-02
|
GO:0031365
|
N-terminal protein amino acid modification
|